Condition (MeSH)
Ureaplasma Infections
ClinicalTrials.gov lists 2 trials for Ureaplasma Infections or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
2 of the 2 trials are tagged with Ureaplasma Infections itself; the rest are tagged with a narrower condition beneath it.
When did Ureaplasma Infections trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2013 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Ureaplasma Infections trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Observational | 1 |
How many Ureaplasma Infections trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Enrolling by invitation | 1 |
| Completed | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which serious adverse events do Ureaplasma Infections trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Patent Ductus Arteriosus | 29 | 1 |
| Sepsis | 15 | 1 |
| Retinopathy of prematurity | 14 | 1 |
| Anemia | 11 | 1 |
| Respiratory Distress | 11 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Ureaplasma Infections? (22)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| U. Parvum serovars exhibit distinct pathogenicity in Chinese women of childbearing age: a multicentre cross-sectional study. | BMC infectious diseases | 2024 | Yes |
| Randomised trial of azithromycin to eradicate <i>Ureaplasma</i> in preterm infants. | Archives of disease in childhood. Fetal and neonatal edition | 2020 | Yes |
| The Human Ureaplasma Species as Causative Agents of Chorioamnionitis. | Clinical microbiology reviews | 2017 | Yes |
| Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis. | American journal of obstetrics and gynecology | 2015 | Yes |
| Association between pulmonary ureaplasma colonization and bronchopulmonary dysplasia in preterm infants: updated systematic review and meta-analysis. | The Pediatric infectious disease journal | 2014 | Yes |
Showing 5 of 22 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.